Skip to content

Transfusion Ratio of Fresh Frozen Plasma (FFP) to Packed Red Blood Cell (PRBC) During Burn Excision and Grafting

A Randomized Prospective Trial of Fresh Frozen Plasma (FFP) to Packed Red Blood Cell (PRBC) Ratio: Comparison of a Traditional (1:4) to Liberal (1:1)FFP Transfusion Policy During Burn Excision and Grafting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05063409
Acronym
FFP
Enrollment
72
Registered
2021-10-01
Start date
2010-09-30
Completion date
2020-02-28
Last updated
2021-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn Injury

Keywords

FFP, PRBC, Burn

Brief summary

The purpose of this study is to determine if burn injured patients who receive blood transfusions in the operating room have better outcomes when given transfusions at a set ratio (1:1)of PRBC to FFP. Traditionally, patients that need blood transfusions during surgery are given mostly packed red blood cells (PRBC) and some fresh frozen plasma (FFP). This is usually about 1:4 ratio of FFP to PRBC. In this study, we will compare this traditional approach (1:4) to a 1:1 ratio of FFP to PRBC during the operative period. The hypothesis of the study is that the use of FFP/PRBC ratio of 1:1, compared to a ratio of 1:4 will result in a(n) 1. decrease in the amount of blood transfused in the operating room 2. decrease in the amount of blood transfused during hospitalization 3. improvement in coagulation parameters (PT/PTT, INR, antithrombin III, Protein C and Fibrinogen in the operative period (from operation start to 12 hours post operatively) and at 24 hours postoperatively 4. decrease the hospital length of stay, lung dysfunction, infections, and mortality

Detailed description

The hypothesis of the study is that the use of a fresh frozen plasma/packed red blood cells (FFP/PRBC) ratio of 1:1, compared to a ratio of 1:4 during operative excision of \>20% TBSA will: result in a decrease in the amount of blood transfused in the operating room, a decrease in the amount of blood transfused during hospitalization, an improvement in coagulation parameters (PT/PTT, INR) in the operative period (from operation start to 12 hours postoperatively) and at 24 hours postoperatively, and a decrease in hospital length of stay, lung dysfunction, number of infections, and mortality. The primary objective of the study is to determine if aggressive correction of intraoperative coagulopathy during burn excision and grafting results in improved outcomes.

Interventions

OTHERTreatment

Blood product transfusion at a ratio of 1:1 FFP to PRBC or 1:4 FFP to PRBC during the operative period (start of surgery to 12 hours post operatively)

Sponsors

Shriners Hospitals for Children
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Months to 18 Years
Healthy volunteers
No

Inclusion criteria

* Patient is 1 month to \</= 18 yrs of age * Admitted to Shriners Hospitals for Children Northern California * Patient has a third degree burn \>/= 20 % total body surface area (TBSA)

Exclusion criteria

* Infants \< 5 kg * Pregnancy * 18 years of age * Inability or unwillingness to receive blood products * Pre-existing need for hemodialysis * Brain death or imminent brain death * Non-survivable burn as determined by the attending burn surgeon * Pre-existing hematologic disease * Closed head injury with Glasgow Coma Score \<9

Design outcomes

Primary

MeasureTime frameDescription
change in the amount of blood transfused in the operating room and during hospitalizationBaseline to 12 months- From date of hospital admit to date of hospital discharge, assessed over duration of hospitalization up to 12 monthsAll transfusions during the operative period and entire hospitalization will be documented

Secondary

MeasureTime frameDescription
change in coagulopathy in the operative period as defined by change in PT/PTT measurementfrom operation start to 12 hours post operativelyPT/PTT obtained pre and post operatively per protocol
change in hospital length of stayFrom date of hospital admit to date of hospital discharge, assessed over duration of hospitalization up to 12 monthsNumber of days in hospital from admit to discharge
change in rate of survivalFrom date of hospital admit to date of hospital discharge, assessed over duration of hospitalization up to 12 monthssurvival outcome as captured at discharge
change in organ dysfunctionFrom date of hospital admit to date of hospital discharge, assessed over duration of hospitalization up to 12 monthsChange in organ dysfunction as evidenced by change in MODS
change in pulmonary dysfunctionFrom date of hospital admit to date of hospital discharge, assessed over duration of hospitalization up to 12 monthspulmonary dysfunction measured by P:F ratio and number of days on mechanical ventilation
change in number of infectious episodesFrom date of hospital admit to date of hospital discharge, assessed over duration of hospitalization up to 12 monthsnumber of new onset infections captured as defined by the Burn Sepsis Consensus Conference

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026